Medical-device company Invenio Imaging is developing technology that enables surgeons to evaluate tissue biopsies in the operating room, immediately after samples are collected - providing in just three minutes AI-accelerated insights that would otherwise take weeks to obtain from a pathology lab.
In a surgical biopsy, a medical professional removes samples of cells or tissue that pathologists analyze for diseases such as cancer. By delivering these capabilities through a compact, AI-powered imaging system within the treatment room, Invenio aims to support rapid clinical decision-making.
This technology will help surgeons make intraoperative decisions when performing a biopsy or surgery, said Chris Freudiger, chief technology officer of Silicon Valley-based Invenio. They'll be able to rapidly evaluate whether the tissue sample contains cancerous cells, decide whether they need to take another tissue sample and, with the AI models Invenio is developing, potentially make a molecular diagnosis for personalized medical treatment within minutes.
Quicker diagnosis enables quicker treatment. It's especially critical for aggressive types of cancer that could grow or spread significantly in the weeks it takes for biopsy results to return from a dedicated pathology lab.
Invenio is a member of NVIDIA Inception, a program that provides cutting-edge startups with technological support and AI platform guidance. The company accelerates AI training and inference using NVIDIA GPUs and software libraries.
Laser Focus on Cancer Care The NIO Laser Imaging System accelerates the imaging of fresh tissue biopsies. Invenio's NIO Laser Imaging System is a digital pathology tool that accelerates the imaging of fresh tissue biopsies. It's been used in thousands of procedures in the U.S. and Europe. In 2021, it received the CE Mark of regulatory approval in Europe.
The company plans to adopt the NVIDIA Jetson Orin series of edge AI modules for its next-generation imaging system, which will feature near real-time AI inference accelerated by the NVIDIA TensorRT SDK.
We're building a layer of AI models on top of our imaging capabilities to provide physicians with not just the diagnostic image but also an analysis of what they're seeing, Freudiger said. With the AI performance provided by NVIDIA Jetson at the edge, they'll be able to quickly determine what kinds of cancer cells are present in a biopsy image.
Invenio uses a cluster of NVIDIA RTX A6000 GPUs to train neural networks with tens of millions of parameters on pathologist-annotated images. The models were developed using the TensorFlow deep learning framework and trained on images acquired with NIO imaging systems.
The most powerful capability for us is the expanded VRAM on the RTX A6000 GPUs, which allows us to load large batches of images and capture the variability of features, Freudiger said. It makes a big difference for AI training.
On the Path to Clinical Deployment One of Invenio's AI products, NIO Glioma Reveal, is approved for clinical use in Europe and available for research use in the U.S. to help identify areas of cancerous cells in brain tissue.
A team of Invenio's collaborators from the University of Michigan, New York University, University of California San Francisco, the Medical University of Vienna and University Hospital of Cologne recently developed a deep learning model that can find biomarkers of cancerous tumors with 93% accuracy in 90 seconds.
With this ability to analyze different molecular subtypes of cancer within a tissue sample, doctors can predict how well a patient will respond to chemotherapy - or determine whether a tumor has been successfully removed during surgery.
Beyond its work on brain tissue analysis, Invenio this year announced a clinical research collaboration with Johnson & Johnson's Lung Cancer Initiative to develop and validate an AI solution that can help evaluate lung biopsies. The AI model will help doctors rapidly determine whether collected tissue samples contain cancer.
Lung cancer is the world's deadliest form of cancer, and in the U.S. alone, lung nodules are found in over 1.5 million patients each year. Once approved for clinical use, Invenio's NIO Lung Cancer Reveal tool aims to shorten the time needed to analyze tissue biopsies for these patients.
As part of this initiative, Invenio will run a clinical study before submitting the NVIDIA Jetson-powered AI solution for FDA approval.
Subscribe to NVIDIA healthcare news.
North America Stories
12/12/2025
SVG Summit 2025 Preview: Everything You Need to Know for Next Week's Big Sho...
12/12/2025
Hailey Gates at the Atropia premiere (photo by George Pimentel / Shutterstock for Sundance Film Festival)...
12/12/2025
CONWAY, Ark. In a notable example of how the elimination of Federal federal funding is forcing public stations to make massive cuts and changes in the way they...
12/12/2025
Wisycom and DPA Microphones announce the appointment of Ren Moerch as Group Product Director, Wireless, a strategic leadership role that will guide the combine...
12/12/2025
SMPTE , the home of media professionals, technologists, and engineers, in conjuncture with the European Broadcasting Union (EBU) and the Entertainment Technolog...
12/12/2025
Keepit, the vendor-independent, cloud-native data protection provider, today announced a strategic go-to-market relationship in Poland with Ingram Micro, a lead...
12/12/2025
Atomos announced the immediate availability of a new firmware update for its Ninja TX GO and Ninja TX monitor-recorders, unlocking Open Gate 48P RAW recording w...
12/12/2025
Professional Wireless Systems (PWS) once again played a critical role in delivering flawless wireless coordination and support at the 2025 Latin Grammy Awards a...
12/12/2025
The Alliance for IP Media Solutions (AIMS), together with the Video Services Forum (VSF), the Advanced Media Workflow Association (AMWA) and the European Broadc...
12/12/2025
DHD audio will demonstrate the latest additions to its range of digital audio production solutions on Booth 321 in Hall B6 at Hamburg Open 2026. The show will b...
12/12/2025
Chaos today announces the release of V-Ray for Blender, update 2, bringing its award-winning rendering technology to even more Blender users by adding support f...
12/12/2025
Lighting specialist UltraLEDs has launched Precision LED Tape, a high-CRI lighting solution designed specifically for professional film, TV, and studio use.
P...
12/12/2025
Zixi, the Emmy Award-winning leader in live broadcast-quality video over IP, today announced that Roi Sasson has joined the company as Vice President, Engineer...
12/12/2025
BitFire (bitfire.tv), the leader in software-defined live production and IP transmission, today announced a strategic partnership with Appear, a leader in high-...
12/12/2025
LOS ANGELES The Hollywood Professional Association (HPA) today said futurist Robert Tercek, creative technologist Jessie Hughes from Leonardo.AI and Emmy-winnin...
12/12/2025
HUDSON, Mass. BitFire and Appear have struck a strategic partnership aimed at offering broadcasters, sports leagues and streaming platforms a faster, more flexi...
12/12/2025
The broadcast industry is evolving faster than ever. #IPWorkflows #remoteproduction, and next-gen audio systems are reshaping how teams design, deliver, and sca...
12/12/2025
LOS ANGELES The payroll and production accounting platform Wrapbook has announced the acquisition of Cinapse, a modern scheduling platform for film and televisi...
12/12/2025
DEHLI Ross Video has announced that it is expanding and restructuring its commercial and technical teams in the South Asian Association for Regional Cooperation...
12/12/2025
LONDON Following the success of its UK launch in January 2025, Rise AV, the global not-for-profit initiative dedicated to supporting and advancing women in the ...
12/12/2025
SAN FRANCISCO Ad-supported streaming service Tubi next week will launch Matter Casting, a new casting standard that will enable seamless mobile-to-TV viewing di...
12/12/2025
LOS ANGELES The Hollywood Professional Association (HPA) today said futurist Robert Tercek, creative technologist Jessie Hughes from Leonardo.AI and Emmy-winnin...
12/12/2025
In Las Vegas's T-Mobile Arena, fans of the Golden Knights are getting more than just hockey - they're getting a taste of the future. ADAM, a robot devel...
12/12/2025
Scripps Research team pioneers an efficient way to stereoselectively add fluorine to drug-like molecules A new method uses a novel catalyst and inexpensive fluo...
11/12/2025
ESPN's Aims for Spectacular With Heisman Trophy ShowEvent firsts include 1080p HDR production airing on both national broadcast and cableBy Dan Daley, Audio...
11/12/2025
SVG Students To Watch: Frankie Patton, University of ColoradoThe 2025 grad is hitting the ground running as a PA on national broadcastsBy Brandon Costa, Directo...
11/12/2025
SVG Summit 2025 Technology Exhibits Preview, Part 3By SVG Staff
Thursday, December 11, 2025 - 7:24 am
Print This Story | Subscribe
Story Highlights
The 2...
11/12/2025
SVG Sit-Down: What Makes Gen Z, X, and Y Fans Tick? Dave Gavant of WSC Sports Go...
11/12/2025
SVG Summit 2025 Preview: 5G, MXL, Spectrum Loss, and Outerspace on Tap for Tues...
11/12/2025
2025 Sports Broadcasting Hall of Fame: David Levy, Turner Titan and Master of Al...
11/12/2025
SVG Launches Follow the Money' Podcast: Go Inside the Sports Media Biz with...
11/12/2025
A Deep Dive Inside Game Creek Video's Bird and Magic Mobile Units, Home to A...
11/12/2025
How Sound Effects for Monsters Funday Football' Emulated the Sonic Soul of ...
11/12/2025
SVG New Sponsor Spotlight: CSP Mobile Productions' Len Chase on Upgrading Tr...
11/12/2025
New satellites for the SDA Tranche 1 Tracking program in production at L3Harris&...
11/12/2025
The Meadowlands system, a compact and mobile version of the CCS, uses ground-based radio frequency units to disrupt satellite communications....
11/12/2025
The L3Harris demonstration united tactical communications devices, counter-UAS c...
11/12/2025
Throughout 2025, L3Harris delivered innovative solutions to U.S. and allied warfighters across every domain.
With an unrelenting commitment to excellence, our...
11/12/2025
A Majority of the World's Population (51%) Identify As Soccer Fans
The 2025 MLB postseason notched 58.2 billion viewing minutes, up +24% from the prior y...
11/12/2025
WALTHAM, Mass. Video-over-IP software provider Zixi said Roi Sasson has joined the company as vice president, engineering....
11/12/2025
MOUNTAIN VIEW, Calif. In a move that highlights the growing competition between broadcasters and CTV platforms for local advertising, LG Ad Solutions has announ...
11/12/2025
Boston Conservatory Earns Several Best of Accolades in 2025 Highlights include a faculty Grammy win, a seventh consecutive year on Playbill's list of co...
11/12/2025
RASTATT, Germany Lawo and the Society of Motion Picture and Television Engineers (SMPTE) have partnered to launch the SMPTE ST 2110 Practical Lab, an immersive ...
11/12/2025
PHILADELPHIA Comcasts Xfinity operating brand has announced the launch of new national video plans with all-in pricing that the operator said will provide custo...
11/12/2025
After eight years of declines, MoffettNathansons new Cord Cutting Monitor for Q3 2025 shows that pay TV subscribers to linear TV packages rose by 303,000, the f...
11/12/2025
Happy Holidays from Berklee Enjoy this years holiday student-performance video.
December 10, 2025
By
Office of the President
Dear Berklee community,
As w...
11/12/2025
Back to All News
The Teaser Trailer and the Key Art of Motorvalley, the New Ser...
11/12/2025
Back to All News
Trailer for the Fourth Season of Alpha Males
Entertainment
11 December 2025
GlobalSpain
Link copied to clipboard
DERECONSTRUCT OR DIE
Do...
11/12/2025
Unveiling what it describes as the most capable model series yet for professional knowledge work, OpenAI launched GPT-5.2 today. The model was trained and deplo...
Medical-device company Invenio Imaging is developing technology that enables surgeons to evaluate tissue biopsies in the operating room, immediately after samples are collected - providing in just three minutes AI-accelerated insights that would otherwise take weeks to obtain from a pathology lab.
